[Clinical significance of serum erythropoietin detection in patients with cancer-related anemia].

Objective: To explore the clinical significance of serum erythropoietin (EPO) detection in patients with cancer-related anemia for improving the life quality of the cancer patients in advanced stage with repeated chemotherapy.

Method: The serum EPO levels were determined in 38 cases of cancer-related anemia with enzyme-linked immunosorbent assay (ELISA).

Results: In 24 patients, the serum EPO level was elevated above the normal range, and lowered EPO level was detected in only 1 cases.

Conclusion: Normal or elevated serum EPO level in patients with cancer-related anemia indicates strong abilities of the patients in self regulation, having important clinical implications for the use of EPO.